The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor
Open accessAbstract
SUMMARY Protein kinase C (PKC) isozymes have remained elusive cancer targets despite the unambiguous tumor promoting function of their potent ligands, phorbol esters, and the prevalence of their mutations. We analyzed 8% of PKC mutations identified in human cancers and found that, surprisingly, most were loss of function and none were activating. Loss-of-function mutations occurred in all PKC subgroups and impeded second-messenger binding, phosphorylation, or catalysis. Correction of a loss-of-function PKCβ mutation by CRISPR-mediated genome editing in a patient-derived colon cancer cell line suppressed anchorage-independent growth and reduced tumor growth in a xenograft model. Hemizygous deletion promoted anchorage-independent growth, revealing that PKCβ is haploinsufficient for tumor suppression. Several mutations were dominant negative, suppressing global PKC signaling output, and bioinformatic analysis suggested that PKC mutations cooperate with co-occurring mutations in cancer drivers. These data establish that PKC isozymes generally function as tumor suppressors, indicating that therapies should focus on restoring, not inhibiting, PKC activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725
Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. L., Beroukhim, R., & Getz, G. (2011) · Genome Biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,550
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Lung cancer in never smokers — a different disease
Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2190 · Cited by 1,608
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.007 · Cited by 1,415
Protein kinase C and other diacylglycerol effectors in cancer
Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Neckers, L., & Workman, P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1000 · Cited by 891
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Self-citationKornev, A. P., Haste, N. M., Taylor, S. S., & Ten Eyck, L. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607656103 · Cited by 762
Protein kinase C isozymes and the regulation of diverse cell responses
Dempsey, E. C., Newton, A. C., Mochly-Rosen, D., Fields, A. P., Reyland, M. E., Insel, P. A., & Messing, R. O. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l429 · Cited by 737
Self-citationA genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C
Violin, J. D., Zhang, J., Tsien, R. Y., & Newton, A. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302125 · Cited by 552
Self-citationIn vitro studies on the mode of action of the phorbol esters, potent tumor promoters: Part 1
Blumberg, P. M., & Boutwell, R. K. (1980) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448009037493 · Cited by 471
Bivona, T. G., Quatela, S. E., Bodemann, B. O., Ahearn, I. M., Soskis, M. J., Mor, A., Miura, J., Wiener, H. H., Wright, L., Saba, S. G., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.012 · Cited by 467
A helix scaffold for the assembly of active protein kinases
Kornev, A. P., Taylor, S. S., & Ten Eyck, L. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807988105 · Cited by 442
Down-regulation of protein kinase C is due to an increased rate of degradation
Young, S., Parker, P. J., Ullrich, A., & Stabel, S. (1987) · Biochemical Journal · doi:10.1042/bj2440775 · Cited by 430
Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1)
Dutil, E. M., Toker, A., & Newton, A. C. (1998) · Current Biology · doi:10.1016/s0960-9822(98)00017-7 · Cited by 381
Self-citationTargeting the protein kinase C family: are we there yet?
Mackay, H. J., & Twelves, C. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2168 · Cited by 373
An international cohort study of cancer in systemic lupus erythematosus
Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21029 · Cited by 353
Justilien, V., Walsh, M. P., Ali, S. A., Thompson, E. A., Murray, N. R., & Fields, A. P. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.008 · Cited by 293
Atypical Protein Kinase Cι Is an Oncogene in Human Non–Small Cell Lung Cancer
Regala, R. P., Weems, C., Jamieson, L., Khoor, A., Edell, E. S., Lohse, C. M., & Fields, A. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2372 · Cited by 263
Szallasi, Z., Smith, C. B., Pettit, G. R., & Blumberg, P. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42143-0 · Cited by 240
Mellemkjér, L., Andersen, V., Linet, M. S., Gridley, G., Hoover, R., & Olsen, J. H. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400424 · Cited by 231
The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts.
Am, C., Guadagno, S. N., Rs, K., Fabbro, D., & Ib, W. (1993) · PubMed · Cited by 225
Tumor Promotion by Depleting Cells of Protein Kinase Cδ
Lu, Z., Hornia, A., Jiang, Y.-W., Zang, Q., Ohno, S., & Foster, D. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3418 · Cited by 207
Belot, A., Kasher, P. R., Trotter, E. W., Foray, A., Debaud, A., Rice, G. I., Szynkiewicz, M., Zabot, M., Rouvet, I., Bhaskar, S. S., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38008 · Cited by 203
Self-citationControl of Nutrient Stress-Induced Metabolic Reprogramming by PKCζ in Tumorigenesis
Ma, L., Tao, Y., Duran, A., Llado, V., Galvez, A., Barger, J. F., Castilla, E. A., Chen, J., Yajima, T., Porollo, A., et al. (2013) · Cell · doi:10.1016/j.cell.2012.12.028 · Cited by 202
Choi, P. M., Tchou-Wong, K. M., & Weinstein, I. B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4650 · Cited by 185
Mandil, R., Ashkenazi, E., Blass, M., Kronfeld, I., Kazimirsky, G., Rosenthal, G., Umansky, F., Lorenzo, P. S., Blumberg, P. M., & Brodie, C. (2001) · PubMed · Cited by 184
Gallegos, L. L., Kunkel, M. T., & Newton, A. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603741200 · Cited by 183
Self-citationYoshida, K., Liu, H., & Miki, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512074200 · Cited by 182
Dries, D. R., Gallegos, L. L., & Newton, A. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600268200 · Cited by 159
Self-citationKuehn, H. S., Niemela, J. E., Rangel-Santos, A., Zhang, M., Pittaluga, S., Stoddard, J. L., Hussey, A. A., Evbuomwan, M. O., Priel, D. A. L., Kuhns, D. B., et al. (2013) · Blood · doi:10.1182/blood-2012-12-469544 · Cited by 158
B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ
Salzer, E., Santos-Valente, E., Klaver, S., Ban, S. A., Emminger, W., Serwas, N. K., Garncarz, W., Müllauer, L., Kain, R., Boztug, H., et al. (2013) · Blood · doi:10.1182/blood-2012-10-460741 · Cited by 149
Protein kinase Cδ and apoptosis
Reyland, M. E. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351001 · Cited by 148
Use of thapsigargin to study Ca2+ homeostasis in cardiac cells
Rogers, T. B., Inesi, G., Wade, R., & Lederer, W. J. (1995) · Bioscience Reports · doi:10.1007/bf01788366 · Cited by 147
Pongracz, J., Clark, P., Neoptolemos, J. P., & Lord, J. M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610107 · Cited by 137
Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C
Alvaro, V., Lévy, L., Dubray, C., Roche, A., Peillon, F., Quérat, B., & BRESSION, D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077302 · Cited by 129
Protein Kinase C α but not PKCζ Suppresses Intestinal Tumor Formation in ApcMin/+ Mice
Oster, H., & Leitges, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0268 · Cited by 123
Zhang, L., Huang, J., Yang, N., Liang, S., Barchetti, A., Giannakakis, A., Cadungog, M. G., O’Brien-Jenkins, A., Massobrio, M., Roby, K. F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4527 · Cited by 123
Mutagenesis of the C2 Domain of Protein Kinase C-α
Medkova, M., & Cho, W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17544 · Cited by 115
Gould, C. M., Kannan, N., Taylor, S. S., & Newton, A. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808436200 · Cited by 113
Self-citationHansra, G., Bornancin, F., Whelan, R. D. H., Hemmings, B. A., & Parker, P. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32785 · Cited by 110
Hirai, S.-I., Izumi, Y., Higa, K., Kaibuchi, K., Mizuno, K., Osada, S., Suzuki, K., & Ohno, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06517.x · Cited by 110
Neuroprotective versus tumorigenic protein kinase C activators
Nelson, T. J., & Alkon, D. L. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.11.006 · Cited by 97
Protein Kinase Cζ Represses the Interleukin-6 Promoter and Impairs Tumorigenesis In Vivo
Galvez, A. S., Durán, Á., Linares, J. F., Pathrose, P., Castilla, E. A., Abu‐Baker, S., Leitges, M., Díaz-Meco, M. T., & Moscat, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01294-08 · Cited by 89
Protein Kinase C (PKC) Isozymes and Cancer
Kang, J. (2014) · New Journal of Science · doi:10.1155/2014/231418 · Cited by 89
Recent Clinical Trials of mTOR-Targeted Cancer Therapies
As, D., & Zheng, X. (2010) · Reviews on Recent Clinical Trials · doi:10.2174/157488711793980147 · Cited by 75
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins
Myhre, S., Lingjærde, O. C., Hennessy, B. T., Aure, M. R. R., Carey, M. S., Alsner, J., Tramm, T., Overgaard, J., Mills, G. B., Børresen‐Dale, A., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.018 · Cited by 71
GARCIA-PARAMIO, P., Cabrerizo, Y., Bornancin, F., & Parker, P. J. (1998) · Biochemical Journal · doi:10.1042/bj3330631 · Cited by 71
Varga, A., Czifra, G., Tállai, B., Németh, T., Kovács, I., Kovács, L., & Bíró, T. (2004) · European Urology · doi:10.1016/j.eururo.2004.04.014 · Cited by 67
Inhibition of Human p53 Basal Transcription by Down-regulation of Protein Kinase Cδ*
Abbas, T., White, D. E., Hui, L., Yoshida, K., Foster, D. A., & Bargonetti, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306979200 · Cited by 67
Langzam, L., Koren, R., Gal, R., Kugel, V., Paz, A., Farkas, A., & Sampson, S. R. (2001) · American Journal of Clinical Pathology · doi:10.1309/1vkk-hwh7-yvjn-7uf7 · Cited by 66
Intramolecular Conformational Changes Optimize Protein Kinase C Signaling
Antal, C. E., Violin, J. D., Kunkel, M. T., Skovsø, S., & Newton, A. C. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.02.008 · Cited by 63
Self-citationThe proapoptotic tumor suppressor protein kinase C-δ is lost in human squamous cell carcinomas
D'Costa, A. M., Robinson, J. K., Maududi, T., Chaturvedi, V., Nickoloff, B. J., & Denning, M. F. (2005) · Oncogene · doi:10.1038/sj.onc.1209065 · Cited by 62
PKC Delta (PKCδ) Promotes Tumoral Progression of Human Ductal Pancreatic Cancer
Mauro, L. V., Grossoni, V. C., Urtreger, A. J., Yang, C., Colombo, L. L., Morandi, A., Pallotta, M. G., Kazanietz, M. G., Joffé, E. B. D. K., & Puricelli, L. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181bce796 · Cited by 62
Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
Barceló, C., Paco, N., Morell, M., Alvarez-Moya, B., Bota‐Rabassedas, N., Jaumot, M., Vilardell, F., Capellá, G., & Agell, N. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1750 · Cited by 62
Kajimoto, T., Sawamura, S., Tohyama, Y., Mori, Y., & Newton, A. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.184028 · Cited by 60
Self-citationc-Myc phosphorylation by PKCζ represses prostate tumorigenesis
Kim, J. Y., Valencia, T., Abu‐Baker, S., Linares, J., Lee, S. J., Yajima, T., Chen, J., Eroshkin, A. M., Castilla, E. A., Brill, L. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221799110 · Cited by 57
Hernández‐Maqueda, J. G., Luna‐Ulloa, L. B., Santoyo‐Ramos, P., Castañeda‐Patlán, M. C., & Robles‐Flores, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058540 · Cited by 53
Protein Kinase C δ Is a Downstream Effector of Oncogenic K-ras in Lung Tumors
Symonds, J. M., Ohm, A. M., Carter, C. J., Heasley, L. E., Boyle, T. A., Franklin, W. A., & Reyland, M. E. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1511 · Cited by 53
Hill, K. S., Erdogan, E., Khoór, A., Walsh, M. P., Leitges, M., Murray, N. R., & Fields, A. P. (2013) · Oncogene · doi:10.1038/onc.2013.147 · Cited by 49
Discrepancies in Cancer Genomic Sequencing Highlight Opportunities for Driver Mutation Discovery
Hudson, A., Yates, T., Li, Y., Trotter, E. W., Fawdar, S., Chapman, P., Lorigan, P. C., Biankin, A. V., Miller, C. J., & Brognard, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1020 · Cited by 44
Self-citationWu, B., Zhou, H., Hu, L., Mu, Y., & Wu, Y. (2012) · Tumor Biology · doi:10.1007/s13277-012-0614-x · Cited by 43
Analysis of protein kinase C delta (PKCδ) expression in endometrial tumors
Reno, E. M., Haughian, J. M., Dimitrova, I. K., et al. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.05.023 · Cited by 43
Walsh, M. F., Woo, R., Gomez, R., & Basson, M. D. (2004) · Cell Proliferation · doi:10.1111/j.1365-2184.2004.00324.x · Cited by 42
Zhang, L. L., Cao, F. F., Wang, Y., Meng, F. L., Zhang, Y., Zhong, D., & Zhou, Q. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1241-3 · Cited by 41
Gwak, J., Jung, S. J., Kang, D., Kim, E. Y., Kim, D., Chung, Y., Shin, J., & Oh, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00683.x · Cited by 41
Luna‐Ulloa, L. B., Hernández‐Maqueda, J. G., Santoyo‐Ramos, P., Castañeda‐Patlán, M. C., & Robles‐Flores, M. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr190 · Cited by 38
Mosior, M. K., & Newton, A. C. (1998) · Biochemistry · doi:10.1021/bi981344t · Cited by 37
Self-citationNezhat, F. R., Wadler, S., Muggia, F. M., Mandeli, J., Goldberg, G. L., Rahaman, J., Runowicz, C. D., Murgo, A. J., & Gardner, G. J. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.021 · Cited by 36
The PKCα-D294G Mutant Found in Pituitary and Thyroid Tumors Fails to Transduce Extracellular Signals
Zhu, Y., Dong, Q., Tan, B. J., Lim, W. G., Zhou, S., & Duan, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4506 · Cited by 33
Linch, M., Sanz-García, M., Soriano, E., Zhang, Y., Riou, P., Rossé, C., Cameron, A., Knowles, P., Purkiss, A., Kjaer, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004068 · Cited by 33
Down‐regulation of protein kinase C‐α detected in human colorectal cancer
Suga, K., Sugimoto, I., Ito, H., & Hashimoto, E. (1998) · IUBMB Life · doi:10.1080/15216549800201552 · Cited by 29
Koren, R., Langzam, L., Paz, A., Livne, P. M., Gal, R., & Sampson, S. R. (2000) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200006000-00013 · Cited by 26
Loss of protein kinase C δ isozyme immunoreactivity in human adenocarcinomas
Craven, P. A., & DeRubertis, F. R. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02088331 · Cited by 25
Protein Kinase C Alpha and Tumorigenesis of the Endocrine Gland
Prévostel, C., Martin, A., Alvaro, V., Jaffiol, C., & BRESSION, D. (2008) · Hormone Research · doi:10.1159/000185457 · Cited by 20
Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications
Pu, Y., Huang, C., Chen, J.-Y., Kang, W.-Y., Lin, Y., Shiu, Y., Chuang, S.-J., Yu, H., Lai, M., Tsai, Y., et al. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-39 · Cited by 19
Analysing the expression of protein kinase C eta in human hepatocellular carcinoma
Lu, H., Chou, F., Yeh, K., Chang, Y., Hsu, N. C.-H., & Chang, J. (2009) · Pathology · doi:10.3109/00313020903273076 · Cited by 19
Cited by
An, Z., Aksoy, O., Zheng, T., Fan, Q.-W., & Weiss, W. A. (2018) · Oncogene · doi:10.1038/s41388-017-0045-7 · Cited by 668
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
Cox, A. D., Der, C. J., & Philips, M. R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3214 · Cited by 351
Protein kinase C: perfectly balanced
Newton, A. C. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1442408 · Cited by 335
Self-citationRedox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
Marengo, B., Nitti, M., Furfaro, A. L., Colla, R., Ciucis, C. D., Marinari, U. M., Pronzato, M. A., Traverso, N., & Domenicotti, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6235641 · Cited by 319
Metadata
- Authors
- Antal, C. E., Hudson, A. M., Kang, E., Zanca, C., Wirth, C., Stephenson, N. L., Trotter, E. W., Gallegos, L. L., Miller, C. J., Furnari, F. B., Hunter, T., Brognard, J., & Newton, A. C.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 160
- Issue
- 3
- Pages
- 489-502
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2087517352
- Cited by
- 330
- References
- 83
- FWCI
- 16.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.